Retinoids and psoriasis.
D000284:Administration, Oral; D001711:Biotransformation; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005050:Etretinate / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D011701:PUVA Therapy; D011485:Protein Binding; D011565:Psoriasis / Q000188:drug therapy*; D014018:Tissue Distribution
D005050:Etretinate